PDS Biotechnology PDSB
NASDAQ PDSB
$0.22 +0.01 (+4.60%)
At close: Aug 21, 2026 · 4:00 PM EDT

PDS Biotechnology (PDSB) Tax Provisions (2014 - 2025)

PDS Biotechnology's (PDSB) quarterly Tax Provisions came in at -$7.5 million in Q4 2025, down 540.25% on a QoQ basis from -$1.2 million in Q1 2025.

PDS Biotechnology (PDSB) Tax Provisions (2014 - 2025) Analysis & Trends

PDS Biotechnology (PDSB) has 7 years of Tax Provisions data on file, last reported at -$7.5 million in Q4 2025.

  • Quarterly Tax Provisions changed N/A year-over-year to -$7.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$8.7 million (down 896.3% YoY) and the FY2025 annual result came in at -$7.5 million, down 761.71% from the prior year.
  • Tax Provisions fell to -$7.5 million in Q4 2025, from -$1.2 million in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $1095.0 in Q4 2022 to a low of -$7.5 million in Q4 2025.
  • A 5-year average of -$2.1 million and a median of -$1.2 million in 2022 frame the typical range for Tax Provisions.
  • Annual changes were most pronounced in 2022 — Tax Provisions jumped 73.45% — and 2023, when it plunged 99.82%.
  • Tracing PDSB's Tax Provisions over 5 years: stood at -$4.5 million in 2021, then jumped by 100.02% to $1095.0 in 2022, then sank by 99.82% to $2.0 in 2023, then sank by 43458550.0% to -$869169.0 in 2024, then plunged by 761.71% to -$7.5 million in 2025.
  • The last three Tax Provisions figures came in at -$7.5 million (Q4 2025), -$1.2 million (Q1 2025), and -$869169.0 (Q2 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 292.00 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 230.90 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 59.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 15.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 75.45 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 13.31 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -90.33 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 1.90 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 PDS Biotechnology 12.02 Mn 12.02 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 -7.49 Mn
Mar 31, 2025 -1.17 Mn
Jun 30, 2024 -869,169.00
Dec 31, 2023 2.00
Jun 30, 2023 -1.41 Mn
Dec 31, 2022 1,095.00
Jun 30, 2022 -1.20 Mn
Jun 30, 2021 -4.52 Mn
Dec 31, 2015 -1.11 Mn
Dec 31, 2014 -590,675.00